Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Curis Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Curis Inc. May 21, 202494.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Imunon Inc. | Grant or award | +13,166 | $0.85 | $11,125 |
| Jul 31, 2026 | Imunon Inc. | Grant or award | +6,934 | $1.59 | $11,025 |
| May 22, 2026 | Imunon Inc. | Grant or award | +11,148 | $2.20 | $24,526 |
| Mar 20, 2026 | Curis Inc. | Derivative conversion | +133,333 | — | — |
| Aug 4, 2025 | Imunon Inc. | Grant or award | +3,318 | $9.20 | $30,526 |
Questions about James E. Dentzer
What boards is James E. Dentzer on?
James E. Dentzer sits on the boards of Curis Inc. and Imunon Inc.
What company is James E. Dentzer the CEO of?
James E. Dentzer is President & CEO of Curis Inc.
How long has James E. Dentzer served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.